SPECIFICITY/DISTRIBUTION/FUNCTION/GAMMA:DELTA T CELLS
特异性/分布/功能/伽玛:DELTA T 细胞
基本信息
- 批准号:3142139
- 负责人:
- 金额:$ 18.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 1992-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The overall goal of this project is to determine the specificity,
distribution, and function of Tcells bearing the newly described T cell
receptor comprising the gamma:delta heterodimer associated with CD3,
which we refer to as TCR1. Our working hypothesis is that TCR1 is
specific for class I MHC gene products distinct from conventional class I
genes in the murine MHC (class IB), and that their principal role is
surveillance of the integrity of epithelial cell membranes. To test this
hypothesis, the following experiments will be carried out:
Intraepithelial lymphocytes will be isolated and tested for expression of
mRNA encoding TCR genes, and for surface expression of TCR protein by
precipitation with anti-CD3 or anti-TCR antibodies, and by
immunofluorescence for cell surface phenotype and receptor expression
where reagents are available.
Isolated TCR1-bearing T cells will be stimulated with antigen or with
anti-receptor antibody, propagated in IL-2, and cloned and/or hybridized
to TCR-negative T lymphoma cells to provide a stable source of TCR1
bearing T cells.
The function of freshly isolated TCR1 bearing T cells or of cloned lines
or hybrids will be studied using anti-CD3 antibody as a mock ligand. The
activation requirements of resting as well as cloned TCR1 bearing T cells
will be studied, as will the production of lymphokines and the response
to lymphokines of these cells.
Finally, these cells will be used to determine the ligand specificity of
TCR1 bearing T cells isolated from epithelia, by stimulation with L cells
transfected with various MHC genes. If such a gene does activate a TCR1
bearing cell, its expression in normal, infected and transformed cells of
that tissue will be examined to determine if differential expression of
that gene could account for TCR1-mediated epithelial surveillance.
本项目的总体目标是确定特异性,
携带新描述的T细胞的T细胞的分布和功能
包含与CD 3相关的γ:δ异二聚体的受体,
我们称之为TCR 1。 我们的工作假设是TCR 1是
特异于不同于常规I类MHC基因产物的I类MHC基因产物
基因在鼠MHC(IB类),其主要作用是
监测上皮细胞膜的完整性。 为了验证这一
假设,将进行以下实验:
将分离上皮内淋巴细胞并检测其表达,
用于TCR蛋白的表面表达,
用抗CD 3或抗TCR抗体沉淀,以及
细胞表面表型和受体表达免疫荧光
在试剂可用的地方。
分离的携带TCR 1的T细胞将用抗原刺激或用
抗受体抗体,在IL-2中增殖,并克隆和/或杂交
TCR阴性T淋巴瘤细胞,以提供稳定的TCR 1
携带T细胞
新鲜分离的携带TCR 1的T细胞或克隆系的功能
或将使用抗CD 3抗体作为模拟配体来研究杂交体。 的
静息以及克隆的携带TCR 1的T细胞的活化要求
将进行研究,淋巴因子的产生和反应也将如此。
这些细胞的淋巴因子。
最后,这些细胞将被用于确定的配体特异性
通过用L细胞刺激从上皮分离的携带TCR 1的T细胞
用各种MHC基因转染。 如果这样的基因确实激活了TCR 1
其在正常、感染和转化细胞中的表达,
该组织将被检查以确定是否差异表达
该基因可以解释TCR 1介导的上皮监视。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES A JANEWAY其他文献
CHARLES A JANEWAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES A JANEWAY', 18)}}的其他基金
ROLE OF CD8 T CELLS IN INITIATION OF AUTOIMMUNE DIABETES
CD8 T 细胞在引发自身免疫性糖尿病中的作用
- 批准号:
6564340 - 财政年份:2001
- 资助金额:
$ 18.55万 - 项目类别:
PATHOGENESIS AND PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
实验性过敏性脑脊髓炎的发病机制及预防
- 批准号:
6484676 - 财政年份:2001
- 资助金额:
$ 18.55万 - 项目类别:
ROLE OF CD8 T CELLS IN INITIATION OF AUTOIMMUNE DIABETES
CD8 T 细胞在引发自身免疫性糖尿病中的作用
- 批准号:
6410345 - 财政年份:2000
- 资助金额:
$ 18.55万 - 项目类别:
PATHOGENESIS AND PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
实验性过敏性脑脊髓炎的发病机制及预防
- 批准号:
6340672 - 财政年份:2000
- 资助金额:
$ 18.55万 - 项目类别:
HUMAN TOLL AND RELATED PROTEINS IN INNATE IMMUNITY
人类伤亡和先天免疫中的相关蛋白质
- 批准号:
6336273 - 财政年份:2000
- 资助金额:
$ 18.55万 - 项目类别:
HUMAN TOLL AND RELATED PROTEINS IN INNATE IMMUNITY
人类伤亡和先天免疫中的相关蛋白质
- 批准号:
6201472 - 财政年份:1999
- 资助金额:
$ 18.55万 - 项目类别:
ROLE OF CD8 T CELLS IN INITIATION OF AUTOIMMUNE DIABETES
CD8 T 细胞在引发自身免疫性糖尿病中的作用
- 批准号:
6301178 - 财政年份:1999
- 资助金额:
$ 18.55万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 18.55万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 18.55万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 18.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 18.55万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 18.55万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 18.55万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 18.55万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 18.55万 - 项目类别: